SEC Filings - Aerovate Therapeutics, Inc.

Filing date	Form	Description	View
February 8, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-002169.pdf 0001415889-23-002169.rtf 0001415889-23-002169.xls View HTML
February 8, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-002170.pdf 0001415889-23-002170.rtf 0001415889-23-002170.xls View HTML
February 8, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-002173.pdf 0001415889-23-002173.rtf 0001415889-23-002173.xls View HTML
February 8, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-002172.pdf 0001415889-23-002172.rtf 0001415889-23-002172.xls View HTML
February 8, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-002174.pdf 0001415889-23-002174.rtf 0001415889-23-002174.xls View HTML
February 6, 2023	SC 13D/A	An amendment to a SC 13D filing	0001104659-23-010758.pdf 0001104659-23-010758.rtf 0001104659-23-010758.xls View HTML
February 3, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-001966.pdf 0001415889-23-001966.rtf 0001415889-23-001966.xls View HTML
January 23, 2023	8-K	Report of unscheduled material events or corporate event	0001798749-23-000005.pdf 0001798749-23-000005.rtf 0001798749-23-000005.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
January 23, 2023	4	Statement of changes in beneficial ownership of securities	0001415889-23-001334.pdf 0001415889-23-001334.rtf 0001415889-23-001334.xls View HTML
January 23, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001415889-23-001333.pdf 0001415889-23-001333.rtf 0001415889-23-001333.xls View HTML

Data provided by Kaleidoscope.